Cell Discovery · 2022 · 22 citations · 32 references
Life SciencesCell BiologyImmunologyCell TherapyRegenerative MedicineStem Cell BiologyCell ManufacturingCell-based TherapiesNatural Killer Cell TherapyAntibody-dependent Cell-mediated CytotoxicityAntibody-dependent Cellular CytotoxicityInduced Pluripotent Stem Cell-derived Natural Killer CellsInduced Pluripotent Stem CellsInhibitory Killer Cell Immunoglobulin-like ReceptorsOff-the-shelf Cell TherapyOrganoid FormationStem Cell-based Regeneration
Human pluripotent stem cell (hPSC)-induced NK (iNK) cells are a source of off-the-shelf cell products for universal immune therapy. Conventional methods for iNK cell regeneration from hPSCs include embryoid body (EB) formation and feeder-based expansion steps, which are time-consuming and cause instability and high costs of manufacturing. Here, we develop an EB-free, organoid aggregate method for NK cell regeneration from hPSCs. In a short time-window of 27-day induction, millions of hPSC input can output over billions of iNK cells without the necessity of NK cell expansion feeders. The iNK cells highly express classical toxic granule proteins, apoptosis-inducing ligands, as well as abundant activating and inhibitory receptors. Functionally, the iNK cells eradicate human tumor cells via mechanisms of direct cytotoxicity, apoptosis, and antibody-dependent cellular cytotoxicity. This study provides a reliable scale-up method for regenerating human NK cells from hPSCs, which promotes the universal availability of NK cell products for immune therapy.
32
Integrated analysis of multimodal single-cell data
Yuhan Hao, Stephanie Hao, Erica Andersen‐Nissen et al. · Cell · 2021 · 16K citations · Full text
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu, David Marín, Pinaki P. Banerjee et al. · New England Journal of Medicine · 2020 · 2.1K citations · Full text
Life Sciences, Immunology, Oncology +17